| Product Code: ETC8197958 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Malta continued to see a high concentration of import shipments for non-alcoholic steatohepatitis (NASH) biomarkers, with the top exporting countries being the UK, Germany, Italy, Netherlands, and Spain. Despite a negative growth rate of -50.11% in 2024, the compound annual growth rate (CAGR) from 2020 to 2024 stood at a steady 2.77%. The high Herfindahl-Hirschman Index (HHI) indicates a persistent market dominance among these key exporting countries, suggesting a competitive landscape in the NASH biomarkers market for Malta.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, 2022 & 2032F |
3.3 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Industry Life Cycle |
3.4 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Porter's Five Forces |
3.5 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By Biomarker Type, 2022 & 2032F |
3.6 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Malta |
4.2.2 Growing awareness about the importance of early detection and monitoring of NASH |
4.2.3 Advances in technology leading to the development of more accurate biomarkers for NASH diagnosis and monitoring |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for NASH biomarker tests in Malta |
4.3.2 High costs associated with biomarker development and commercialization |
4.3.3 Regulatory challenges and stringent approval processes for new biomarkers in the market |
5 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends |
6 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Types |
6.1 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Biomarker Type |
6.1.1 Overview and Analysis |
6.1.2 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Type, 2022 - 2032F |
6.1.3 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Serum Biomarkers, 2022 - 2032F |
6.1.4 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Panels, 2022 - 2032F |
6.1.5 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Fibrosis Biomarkers, 2022 - 2032F |
6.1.6 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2022 - 2032F |
6.1.7 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.2.3 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Diagnostic Centers, 2022 - 2032F |
6.2.4 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2022 - 2032F |
7 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Import-Export Trade Statistics |
7.1 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Export to Major Countries |
7.2 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Imports from Major Countries |
8 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Key Performance Indicators |
8.1 Number of research studies and clinical trials focusing on NASH biomarkers in Malta |
8.2 Adoption rate of NASH biomarker tests by healthcare providers in Malta |
8.3 Investment trends in NASH biomarker development and commercialization in Malta |
9 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Opportunity Assessment |
9.1 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By Biomarker Type, 2022 & 2032F |
9.2 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Competitive Landscape |
10.1 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue Share, By Companies, 2025 |
10.2 Malta Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here